Epigenetic regulator explains why some lung cancer patients become resistant to common therapeutics — ScienceDaily
Doctors typically treat people with nonsmall cell lung cancer, a prevalent and typically incurable type of cancer that makes up 80%-85% of lung cancers, with tyrosine kinase inhibitors, specifically epidermal…
